• Who we are
    • About BICO
    • What we do
      • Companies
      • Business areas
    • Sustainability
    • BICO in the press
    • BICO voices
    • What is Bio Convergence?
  • Companies
  • Research
  • Events
  • News
  • Investors
  • English
    • English
    • Svenska
Ir press releases
News
Ir press releases
  • All
  • Regulatory
  • Non-regulatory
11/25/21 BICO ranked top-three fastest-growing technology company in Sweden by Deloitte
11/24/21 CELLINK empowers the Swedish 3Rs Center´s network to create awareness on how to reduce animal testing
11/17/21 BICO Announces Appointment of Susan Tousi as New Member of the Board of Directors
11/17/21 RegulatoryBulletin from the extraordinary general meeting in BICO Group AB (publ)Regulatory
11/16/21 Cellenion Announces Co-Marketing Agreement with Bruker to Deliver Advanced Solutions for Single Cell Mass Spectrometry-Based Proteomics Analysis
11/15/21 Cellenion Announces Co-Marketing Agreement for Single Cell Mass Spectrometry-Based Proteomics Analysis
11/15/21 BICO’s group companies CELLINK and CYTENA win five German Design Awards for Excellent Product Design
11/10/21 RegulatoryInterim report January-September 2021: Continued strong organic growth, improved gross margin and supply chain challengesRegulatory
11/05/21 Invitation to earnings call for interim report January-September 2021
10/29/21 RegulatoryBICO Group AB (publ) announces an increase in number of shares and votesRegulatory
10/26/21 RegulatoryNotice of extraordinary general meeting of BICO Group AB (publ)Regulatory
10/22/21 BICO has been awarded the Swedish Government’s Award Exporter of the Year 2021
10/19/21 CYTENA launches C.STATION, a fully automated platform for stable cell line development to streamline production of antibody and gene therapies
10/15/21 BICO completes the acquisition of QInstruments
10/15/21 BICO has been nominated for the Swedish Government’s Export Success of the Year 2021 Award
10/14/21 BICO strengthens IP Portfolio with Patents in the United States and Sweden for 3D bioprinting of Temperature Sensitive Bioinks
10/08/21 RegulatoryNomination Committee for BICO Group AB in preparation for the 2022 Annual General MeetingRegulatory
10/08/21 RegulatoryBICO has carried out a directed share issue of SEK two billionRegulatory
10/07/21 RegulatoryBICO announces intention to carry out a directed issue of approximately SEK two billionRegulatory
10/01/21 RegulatoryBICO has entered into an agreement to acquire QInstruments, a market leader in advanced sample preparation automation for biomedical and life science research and clinical diagnostics.Regulatory
09/30/21 RegulatoryBICO announces an increase in number of shares and votesRegulatory
09/21/21 BICO Launches 3D Bioprinting contract research offering from CELLINK, MatTek and Visikol
09/15/21 BICO has acquired HUREL micro liver technologies to offer the market’s most comprehensive liver in vitro services
09/07/21 BICO welcomes Erica Bell as Chief People Officer as company nears 1,000 employees globally
08/27/21 BICO has acquired Advanced BioMatrix, an innovative company focused on 3D applications, to, together, ensure a market leading portfolio of bioinks and reagents
08/23/21 DISPENDIX welcomes Petros Apostolopoulos as new CEO to strengthen position as leading liquid handling and lab automation company
08/18/21 Introducing BICO: The Global Leader in the Bio Convergence Revolution
08/18/21 RegulatoryInterim report January-June 2021: Increased net sales of 628% driven by M&A and organic growth of 95% and positive EBITDA in Q2.Regulatory
08/13/21 Change of name and short name (ticker) for shares in CELLINK AB (publ)
08/12/21 The name change has been registered: CELLINK AB (publ) new name is BICO Group AB (publ)
08/12/21 Invitation to earnings call for interim report January-June 2021
08/06/21 RegulatoryBulletin from Extraordinary General Meeting in CELLINK AB (publ)Regulatory
07/30/21 RegulatoryCELLINK announces an increase in number of shares and votesRegulatory
07/19/21 CELLINK launches the S.NEST, a high-throughput microbioreactor with real-time monitoring to ensure maximum cell growth and streamlined workflows
07/07/21 CELLINK has initiated the process of changing name to BICO
07/07/21 RegulatoryNotice of Extraordinary General Meeting of CELLINK AB (publ)Regulatory
07/06/21 Visikol partners with MatTek to leverage their advanced cell culture models in its suite of drug discovery services
06/30/21 CELLINK completes the acquisition of Discover Echo
06/30/21 CELLINK has been granted its first patent of robotic systems for personalized and automated aesthetic medical procedures
06/30/21 RegulatoryCELLINK announces an increase in number of shares and votesRegulatory
06/29/21 CELLINK has been granted a patent for “Cellulose Nanofibrillar Bioink for 3D Bioprinting for Cell Culturing, Tissue Engineering and Regenerative Medicine Applications” from European Patent Office
06/26/21 RegulatoryCELLINK has entered into an agreement to acquire Discover Echo Inc., an innovative and revolutionary microscopy companyRegulatory
06/23/21 CELLINKs EpiDerm ™ skin model has been approved by the OECD as a stand-alone in-vitro test method for phototoxicity
05/31/21 CELLINK completes the acquisition of Nanoscribe
05/24/21 CELLINK Bioprinting moves to Entré Kallebäck
05/20/21 CELLINK has acquired Visikol, a contract research services company focused on advanced imaging, 3D cell culture assays and digital pathology
05/19/21 RegulatoryCELLINK has entered into an agreement to acquire Nanoscribe, a market leading 3D bioprinting company based on Two-Photon Polymerization technologyRegulatory
05/12/21 RegulatoryInterim report January-March 2021: High organic growth, strengthened gross margin, and strategic acquisitionsRegulatory
04/30/21 RegulatoryCELLINK announces an increase in number of shares and votesRegulatory
04/26/21 RegulatoryBulletin from Annual General Meeting in CELLINK AB (publ)Regulatory
  • 1
  • 2
  • 3
  • 4
  • 5
  • →
News
October 14, 2021BICO stärker IP-portföljen med patent i USA och Sverige för 3D-bioprintning av temperaturkänsliga biobläck
  • 1

Stay updated

Get the latest first.

Subscribe
Subscribe and stay updated with the latest news!
Subscribe
  • About BICO
    • Companies
    • Business areas
    • News
  • Investor
    • Investor website
    • Financial reports
    • Financial calendar
  • Policies
    • Supplier code of conduct
    • Internal code of conduct
    • Whistleblower/speak up channel
  • Instagram
  • Twitter
  • Linkedin
Copyright © 2021 BICO - The Bio Convergence Company - All rights reserved.